image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

ITE - Q3 revenues rise 25%

October 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ITE
  • Price:
  • 279p
Shares in ITE have threatened to break through £3 on a number of occasions and remain well placed ahead of our original recommendation price of 164p from October '10.Its Q3 update has added to this momentum with total revenues, including a good performance from the biennial Moscow Oil & Gas (MIOGE) event as well as a first time contribution from a Malaysian exhibition acquired in January, rising 25% to £95m. Meanwhile, in spite of spending £26m on acquisitions it still ended with net cash of £17m as at 12 July (2012: net debt: £1.7m). The group's principal events in the period included the Mosbuild construction show as well as MIOGE, ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X